The DSS1 protein interacts with the breast cancer susceptibility protein BRCA2 that plays an integral role in the repair of DNA double-strand breaks (DSBs). DSS1 has also been shown to interact with components of the 26S proteasome in Saccharomyces cerevisiae and in human tumour cells. This raises the possibility of functional interplay between the DNA repair machinery and the proteasome. We show here that human DSS1 interacts with the RPN3 and RPN7 proteasome subunits and define regions of DSS1 important for the interactions with RPN3, RPN7 and BRCA2. We also show that BRCA2 interacts with RPN3 and RPN7 and that the BRCA2/ RPN7 interaction is independent of DSS1. Finally, and most significantly, we demonstrate that the proteolytic activity of the proteasome is a determinant of the choice of DSB repair pathway; inhibition of proteasome proteolytic activity results in an increase in the utilization of potentially mutagenic single-strand annealing at the expense of a reduction in the level of error-free gene conversion. This confirms a functional link between DSB repair and proteasomal activity.
The DSS1 protein interacts with the breast cancer susceptibility protein BRCA2 that plays an integral role in the repair of DNA double-strand breaks (DSBs). DSS1 has also been shown to interact with components of the 26S proteasome in Saccharomyces cerevisiae and in human tumour cells. This raises the possibility of functional interplay between the DNA repair machinery and the proteasome. We show here that human DSS1 interacts with the RPN3 and RPN7 proteasome subunits and define regions of DSS1 important for the interactions with RPN3, RPN7 and BRCA2. We also show that BRCA2 interacts with RPN3 and RPN7 and that the BRCA2/ RPN7 interaction is independent of DSS1. Finally, and most significantly, we demonstrate that the proteolytic activity of the proteasome is a determinant of the choice of DSB repair pathway; inhibition of proteasome proteolytic activity results in an increase in the utilization of potentially mutagenic single-strand annealing at the expense of a reduction in the level of error-free gene conversion. This confirms a functional link between DSB repair and proteasomal activity. Keywords: DSS1; BRCA2; proteasome; double-strand break DSS1 was originally identified as a candidate gene for the developmental disorder split hand/foot malformation (SHFM) (Crackower et al., 1996) but evidence for a role of the gene in this disease is still lacking. Significant progress in the delineation of DSS1 function was made when DSS1 was discovered to be a BRCA2-binding protein (Marston et al., 1999) . DSS1 associates with a C-terminal portion of BRCA2 (amino acids 2472-2957), later termed the DNA/DSS1-binding domain (DBD) (Yang et al., 2002) . DSS1 has since been shown to be essential for normal BRCA2 function both in mammalian cells (Gudmundsdottir et al., 2004; Li et al., 2006) and in the fungus Ustilago maydis (Kojic et al., 2003 (Kojic et al., , 2005 . DSS1 deficiency creates a phenotype similar to that seen in BRCA2-deficient cells, which is attributable to a defect in homology-directed repair of doublestranded breaks (DSBs) by a subpathway known as gene conversion (GC). GC is dependent upon the recombinase RAD51 and is largely error-free. A decrease in the use of GC in BRCA2-deficient cells is associated with an increase in the use of alternative, more error-prone repair mechanisms such as single-strand annealing (SSA) (Tutt et al., 2001) . Recently, DSS1 has been shown to be a component of the lid subcomplex of the 19S regulatory particle of the 26S proteasome in both yeast and humans and is required for efficient ubiquitindependent protein degradation (Funakoshi et al., 2004; Krogan et al., 2004; Sone et al., 2004; Josse et al., 2006) . A role for the proteasome in DNA repair has previously been reported, including the regulation of nucleotide excision repair (Schauber et al., 1998) . Furthermore, studies in yeast have shown that loss of DSS1 function, and that of other DSB repair proteins, is synthetically lethal with loss of function of nonessential proteasome subunits (Krogan et al., 2004) . This suggests some level of functional interplay between DSB repair and proteasomal function. In mammalian cells, other than the illustration that DSS1 is a component of the 26S proteasome, the interaction between DSB repair and the proteasome is less well defined. Since DSS1 is both a BRCA2-binding protein and a component of the 26S proteasome, we investigated the role of the proteasome in mammalian DNA double-strand break repair and whether DSS1 might act as a link between these two processes.
Previously, it has been shown that the Saccharomyces cerevisiae DSS1 orthologue, Sem1p, is a component of the proteasome lid and forms a complex with the proteasome subunits Rpn3 and Rpn7, an association controlled by Rpn6 (Isono et al., 2005) . Similarly, mass spectrometry of DSS1-containing protein complexes isolated from human HeLa cells identified multiple proteasome subunits (Krogan et al., 2004) . To evaluate the role of human DSS1 in the lid complex, we performed yeast two-hybrid (Y2H) experiments using DSS1 as 'prey' (expressed as part of a transcription activation domain fusion protein) and either human RPN3 (also known as S3 and PSMD3) or RPN7 (also known as S10a and PSMD6) as 'bait' (expressed as protein fusions with the corresponding transcription factor DNA-binding domain). Using the previously described DSS1/BRCA2 interaction (Marston et al., Figure 1b) . Similarly, the DSS1/RPN7 interaction was validated by the demonstration that endogenous mouse RPN7 could be coimmunoprecipitated with the HA-DSS1 fusion protein ( Figure 1c ). While these results cannot completely exclude the possibility that the DSS1/RPN3 and DSS1/RPN7 interactions are indirect, they do suggest that the DSS1/proteasome lid interaction is conserved in mammals.
The three-dimensional structure of DSS1 bound to the C terminus of BRCA2 (Yang et al., 2002) allowed modelling of the interaction between these two proteins. On this basis, DSS1 is proposed to bind BRCA2 via 25 residues present in two highly conserved segments, the BRCA2 interacting region 1 (residues 7-25) and the BRCA2 interacting region 2 (residues 37-63). These two regions are linked by an 11-residue, non-conserved, linker region (Figure 1d ). To assess this model and also DSS1/RPN3 and DSS1/RPN7 interactions, a series of DSS1 mutants were generated and analysed by Y2H using full-length human RPN3, RPN7 or a C-terminal BRCA2 fragment (BRCA2.IV, aa 2472-2957) as described by Marston et al. (1999) (Figure 1d ). The N-terminal nine residues of DSS1 appear not to be required for the interactions with RPN3, RPN7 or BRCA2. Furthermore, three amino acids (LGL) within the DSS1 N terminus (aa 10-12) are an absolute requirement for the interaction with BRCA2 (mutants 2-4) indicating that the DSS1 hydrophobic helical region (a1) is crucial. However, amino acids 10-12 of DSS1 are not in themselves sufficient for BRCA2 binding as demonstrated by the decreased interaction of mutants 9 and 10. Interestingly, the three-dimensional structure of the BRCA2 C terminus/DSS1 suggests that residues 11-13 of DSS1 lie buried below the surface of the BRCA2 helical area (the only residues of DSS1 to do so), again highlighting the importance of the a1 domain (Figure 1d ).
The role of the DSS1 C terminus and interactions between the N-and C-termini of this protein were also examined. Mutants 5-8 indicated that the C-terminal 14 residues of DSS1 (aa 57-70) are redundant for the interaction with BRCA2, suggesting the lesser importance of the DSS1 a3 domain (Figure 1d ). Furthermore, mutants 8-12 not only confirm the importance of the N terminus for the BRCA2/DSS1 interaction but also suggest that this interaction is likely to be stabilized by amino acids in the b2 and/or a2 domains. The interaction of mutant 17 highlights the importance of the R57 residue. This residue of DSS1 is proposed to form a salt bridge with residue D16 and its loss, while not altering the BRCA2 interaction when the entire BRCA2 interaction region 1 is present (compare mutants 7 and 8), does alter the interaction when only the minimal 10-12 region is present (compare mutants 14-17). This suggests that the R57-D16 salt bridge may stabilize the a1 domain and the structure of DSS1 (Figure 1d ). DSS1 mutants were also informative with respect to DSS1/RPN3 and DSS1/RPN7 interactions. Mutants 9-12 suggest that the C-terminal 34 amino acids of DSS1 are essential for the DSS1/RPN7 interaction (in contrast to the importance of the N terminus in BRCA2 binding) and that the DSS1 linker domain can inhibit the RPN7-binding properties of C-terminal DSS1. The Y2H data also suggest that RPN3 binds the N terminus of DSS1 and that again, the linker region is inhibitory. The inhibitory action of the linker domain in RPN3 and Figure 1 Delineation of human DSS1 interactions with RPN3, RPN7 and BRCA2. (a) Interaction of human DSS1 and RPN3 or RPN7 in a yeast two-hybrid (Y2H) system. All Y2H analyses were performed using the Matchmaker kit (Clontech, Mountain View, CA, USA) according to the manufacturer's instructions. RPN3, RPN7 and BRCA2.IV were expressed as DNA-binding domain fusion proteins, using the pASN vector, while DSS1 and DSS1 mutants were expressed as activation domain fusion proteins using pACTII. In this instance, pACTII-DSS1 was co-transformed with pASN-RPN3 or pASN-RPN7 into Y190 yeast and double transformants were selected on SD-TRP-LEU (TL) plates. For interaction analysis, these plates were replicated onto SD-TRP-LEU-HIS (TLH) selection plates, supplemented with 50 mM 3-Amino Triazole (AT). Interaction with BRCA2.IV was used as a positive control (Marston et al., 1999) . Yeast growth on TLH plates indicates bait and prey interaction. (b) Interaction of human DSS1 and RPN3 in mammalian cells. Full-length human DSS1 cDNA was cloned into pEF (Invitrogen, Carlsbad, CA, USA) along with a haemagglutinin (HA) epitope at the N terminus. This construct (HA-DSS1) was co-transfected into MCF7 human breast cancer cells (ATCC, Teddington, Middlesex, UK) with a similar pEF-Bsd construct encoding full-length human RPN3 with an N-terminal myc epitope (myc-RPN3). Transfections were performed using FuGENE6 (Roche, Indianapolis, IN, USA). pEF-Bsd control constructs encoding only the HA or myc epitopes were used where appropriate (HA-empty and myc-empty). Cell lysates were generated 48 h after transfection, and HA epitopecontaining proteins immunoprecipitated and electrophoresed using standard techniques. Anti-HA antibody (Sigma, Poole, Dorset, UK) was used for immunoprecipitation or anti-IgG antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) as a negative control. Immunoblots were probed (immunoblotted (IB)) with an anti-c-myc antibody (Upstate Biotechnology, Charlottesville, VA, USA) to detect RPN3. Ten per cent of each lysate was loaded alongside immunoprecipitates to act as a transfection control and the immunoblot was stripped and reprobed with anti-b-tubulin (Sigma, UK) to control for loading. The immunoblots shown indicate that human RPN3 co-immunoprecipitates with human DSS1. (c) Interaction of DSS1 and RPN7 in mammalian cells. HA-DSS1 or HA-empty was transfected into 67CO embryonic stem (ES) cells (Tutt et al., 2001 ) using Lipofectamine 2000 (Invitrogen, Paisley, UK). Immunoprecipitations were carried out as before. Immunoblots were probed with an anti-RPN7 antibody (Affiniti Research, Palo Alto, CA, USA). Ten per cent of each lysate was loaded alongside to act as a loading control and probed for endogenous RPN7. The immunoblots shown indicate that mouse RPN7 co-immunoprecipitates with human DSS1. (d) Assessment of DSS1 interactions with BRCA2, RPN3 and RPN7. Y2H was performed as described above. The secondary structure of DSS1 when bound to BRCA2 is shown above the primary sequence. BRCA2 interacting residues (as described by Yang et al. (2002) Proteasome and DSB repair pathways K Gudmundsdottir et al RPN7 binding is most likely an artefact of the Y2H system; in the absence of either the N or C domain, the linker domain of DSS1 may lose its normal structure and interfere with DSS1 partner binding. Mutant 13 further defines the RPN3-binding domain to the acidic region (high D and E content) from residues 15 to 25 of DSS1 (Figure 1d) .
Having validated the DSS1/RPN3 and DSS1/RPN7 interactions, potential interactions of BRCA2 with proteasome components were also investigated. Human MCF7 cells were transfected with constructs expressing HA-tagged RPN3. Endogenous BRCA2 was shown to co-immunoprecipitate with HA-RPN3, suggesting a BRCA2/RPN3 interaction (Figure 2a) . Furthermore, using mouse embryonic stem (ES) cells (67CO) carrying an endogenous myc epitope-tagged Brca2 allele (Tutt et al., 2001) , we were able to co-immunoprecipitate Brca2 with endogenous Rpn7, strengthening the link between BRCA2 and the proteasome (Figure 2b) . As BRCA2 and DSS1 are both required for the repair of DNA DSBs (Tutt et al., 2001; Gudmundsdottir et al., 2004) , it is possible that the DSS1/proteasome and Immunoblots are shown from immunoprecipitates generated from 67CO mouse embryonic stem (ES) cells containing an endogenous Brca2 allele tagged with the myc epitope (Tutt et al., 2001) . Wild-type ES cells were used as a negative control. (c) The DSS1/Rpn7 interaction is not modified by DNA damage. 67CO ES cells were transfected (D3) with pEF-HA-DSS1 or pEF-HA-empty construct and irradiated (10 Gy) 24 h later. Cell lysates were generated at 30 min, 2 h and 4 h post-irradiation. IBs are shown indicating no significant change in the amount of Rpn7 co-immunoprecipitated with DSS1. (d) The Brca2/Rpn7 interaction is not modified by DNA damage. 67CO ES cells were irradiated (10 Gy) and cell lysates generated 30 min, 2 h and 4 h later. Immunoblots are shown indicating no significant change in the amount of Rpn7 co-immunoprecipitated with endogenous, myc-tagged Brca2.
BRCA2/proteasome interactions are modified after DSB formation. However, assessment of the DSS1/ Rpn7 and Brca2/Rpn7 interactions in the 4 h following DSB formation did not indicate significant changes as assessed by co-immunoprecipitation (Figures 2c and d) .
Since DSS1 binds both BRCA2 and proteasome subunits, the possibility that DSS1 acts as a link between BRCA2 and the proteasome was investigated. RNA interference was used to silence the expression of endogenous DSS1 by transiently transfecting ES cells with previously validated pSUPER constructs (Brummelkamp et al., 2002) expressing either a short-hairpin (sh)RNA targeting mouse Dss1 (pSUPER-mDss1) or a non-targeting shRNA control (pSUPER-NS) (Gudmundsdottir et al., 2004) . Despite a high transfection efficiency (70%, assessed using a GFP marker on the pSUPER backbone, data not shown), Dss1 depletion was not observed to have a detectable effect on the interaction between Brca2 and Rpn7 (Figure 3b ). These results were confirmed using transfection of shortinterfering RNAs (siRNA) (Figures 3a and c) . These results indicated that the BRCA2/RPN7 interaction is not dependent on the presence of DSS1.
While this experiment suggests that DSS1 control of the BRCA2-proteasome interaction is unlikely, the interactions we describe here suggest that the proteasome is likely to play some role in the repair of DSBs by GC, a major function ascribed to BRCA2. To assess this possibility, the effect of proteasome inhibition on the extent of homologous recombination (HR) was assessed using an ES cell line containing an HR repair substrate (DR1Bsd). This cell line carries a chromosomally integrated repair substrate, in which a single DSB can be generated by the transient expression of the I-Sce I endonuclease and the extent of GC-mediated or SSA events measured via variations in antibiotic resistance. This system has previously been used to demonstrate a role for Brca2 in the repair of DSBs by GC (Tutt et al., 2001) . To inhibit proteasome function, we used the potent small molecule inhibitor epoxomicin (Sin et al., 1999) . No change was observed in the overall frequency of HR events (P ¼ 0.674) but in experiments analysed for relative GC and SSA events, SSA was increased in epoxomicin-treated cells at the expense of GC events (Table 1) ES cells were transfected with either pSUPER-eGFP-NS (expressing a non-targeting short-hairpin (sh)RNA) or pSUPER-eGFPmDss1 (expressing a shRNA targeting Dss1) (Gudmundsdottir et al., 2004) . Lysates were generated 48 h later. Immunoblots are shown from anti-Rpn7 or control (anti-IgG) immunoprecipitates probed for the myc epitope on endogenous Brca2 in this cell line. No detectable difference in the Brca2/Rpn7 interaction was observed nor was any change in the levels of Brca2 stability, as we have previously reported (Gudmundsdottir et al., 2004) . (c) The Brca2/Rpn7 interaction as assessed by siRNA. This experiment was performed as in (b) substituting pSUPER constructs with siRNA transfection. Lysates were generated at 48 h, post transfection. Abbreviations: DSB, double-strand breaks; GC, gene conversion; HR, homologous recombination; SSA, single-strand annealing. Measurement of DSB repair pathway usage was carried out as previously described (Tutt et al., 2001 ) using a mouse embryonic stem cell line containing an HR repair substrate (DR1Bsd). This cell line carries a chromosomally integrated repair substrate, in which a single DSB can be generated by the transient expression of the I-Sce I endonuclease. The extent of GC-mediated or SSA events was measured by alterations in antibiotic resistance. Cells were transfected with the I-Sce I expression plasmid and treated with epoxomicin (40 nM, 6 h exposure) 4 h later. *P-values were calculated using an unpaired t-test. **Pvalues were calculated using a w 2 test.
some function shifts the repair process of direct repetitive elements from GC repair to more error-prone SSA in mammalian cells. Taken together, these results indicate a role for the proteasome in the choice of repair pathway. Here, we show, for the first time, that the DNA repair protein, BRCA2, interacts with the DSS1-binding proteasome subunits RPN3 and RPN7. Surprisingly, the BRCA2/RPN7 interaction does not seem to be mediated by DSS1. These results suggest an intriguing scenario whereby BRCA2 could act to bring the proteasome to the DNA repair machinery. Our data further suggest an involvement of proteolysis in the repair of DSBs, as inhibiting the proteasome affects the pathway by which DSBs are repaired. Therefore, blockade of the proteasomal pathway may sensitize cells to specific DNA-damaging agents.
